The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM)

Our Recent Publication: Sickle cell allele HBB-rs334(T) is associated with decreased risk of childhood Burkitt lymphoma in East Africaca
The Epidemiology of Burkitt lymphoma in East African children and minors (EMBLEM) is a research study sponsored by the Intramural Research program of the National Cancer Institute under Protocol #: 10-C-N133 during 2010-2016 to comprehensively investigate infections, immunological, and genetic risk factors of Burkitt lymphoma (BL).
See more details on our Study Summary page.News
June 17, 2023
EMBLEM presents Late Breaker Abstract at ICML in Lugano
June 9, 2023
June 22, 2022
Sam Mbulaiteye Receives Lymphoma Foundation of America’s 2022 Scientist of the Year Award
March 10, 2022
Videos
Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda
by Kirimunda et al.
Risk factors for Burkitt lymphoma in East African children and minors: A case–control study in malaria‐endemic regions in Uganda, Tanzania and Kenya
by Peprah et al.